Sales milestone: Cosmos Health announced annualized sales exceeding $1.5 million for its C-Scrub and C-Sept antiseptic brands in the UK and Greece.
Expansion plans: The company outlined ambitions for EU growth targeting $7.4 million in revenue and $5.3 million in gross profit by 2028, including animal healthcare initiatives.
Market reaction: Social media commentary highlighted these developments alongside recent manufacturing expansions, with observers noting ongoing concerns over share performance in recent months.
Note: This discussion summary was generated from an AI condensation of post data.
Cosmos Health Inc. Insider Trading Activity
Cosmos Health Inc. insiders have traded $COSM stock on the open market 13 times in the past 6 months. Of those trades, 13 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $COSM stock by insiders over the last 6 months:
- GRIGORIOS SIOKAS (Chief Executive Officer) has made 13 purchases buying 3,321,823 shares for an estimated $1,298,000 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Cosmos Health Inc. Revenue
Cosmos Health Inc. had revenues of $19.7M in Q4 2025. This is an increase of 38.52% from the same period in the prior year.
You can track COSM financials on Quiver Quantitative's COSM stock page.
You can access data on COSM stock through the Quiver Quantitative API.
Cosmos Health Inc. Hedge Fund Activity
We have seen 8 institutional investors add shares of Cosmos Health Inc. stock to their portfolio, and 13 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GEODE CAPITAL MANAGEMENT, LLC added 119,427 shares (+60.1%) to their portfolio in Q1 2026, for an estimated $37,882
- CITADEL ADVISORS LLC removed 82,850 shares (-67.3%) from their portfolio in Q1 2026, for an estimated $26,280
- XTX TOPCO LTD removed 59,133 shares (-59.4%) from their portfolio in Q1 2026, for an estimated $18,756
- RENAISSANCE TECHNOLOGIES LLC added 55,925 shares (+16.7%) to their portfolio in Q1 2026, for an estimated $17,739
- HRT FINANCIAL LP added 41,619 shares (+162.2%) to their portfolio in Q1 2026, for an estimated $13,201
- TWO SIGMA SECURITIES, LLC removed 36,290 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $11,511
- STONEX GROUP INC. removed 19,300 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $9,611
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
